BioLineRx Investor Relations Material
Latest events
Q2 2025
BioLineRx
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BioLineRx Ltd
Access all reports
BioLineRx Ltd. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapeutics for oncology and rare diseases. The company's primary product pipeline includes therapies aimed at treating multiple myeloma, sickle cell disease, pancreatic cancer, and other solid tumors. BioLineRx leverages extensive drug development expertise to advance these therapies from preclinical stages through to commercialization. The company is headquartered in Hevel Modi'in, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
BLRX
Country
🇺🇸 United States